Genetic Technologies Limited (NASDAQ:GENE) currently has a “Hold” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Genetic Technologies Limited (NASDAQ:GENE) gained 35.78 Percent and closed its previous trading session at $1.48. The stock traded with the average Volume of 57.47 Million at the end of last session.
Genetic Technologies Limited (NASDAQ:GENE) has the Market Capitalization of 24.3 Million. The Stock has its 52-week High of $2.05 and 52-Week Low of $0.70 and it touched its 52-week high on 01/17/18 and 52-Week Low on 08/23/17
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 41.78% where SMA50 and SMA200 are 31.3% and 29.73% respectively.
The company shows its Return on Assets (ROA) value of -60.5%. The Return on Equity (ROE) value stands at -68.6%. While it’s Return on Investment (ROI) value is -71.2%.
Genetic Technologies Limited (NASDAQ:GENE) currently has a Weekly Volatility of 13.83% percent while its Monthly Volatility is at 6.96% percent. While talking about Performance of the Stock, Genetic Technologies Limited currently has a Weekly performance of 39.62%, monthly performance percentage is 33.33 percent, Quarterly performance is 8.03 percent, 6 months performance shows a percent value of 29.82% and Yearly Performance is 70.1 percent.
Genetic Technologies was the first company in the world to recognize important new applications for non-coding DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.